SciELO - Scientific Electronic Library Online

 
vol.20 número2Anticoagulante lúpico en enfermedades autoinmunes índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Articulo

Indicadores

  • No hay articulos citadosCitado por SciELO

Links relacionados

  • No hay articulos similaresSimilares en SciELO

Compartir


Revista Cubana de Hematología, Inmunología y Hemoterapia

versión On-line ISSN 1561-2996

Resumen

CAYADO GUTIERREZ, Niubys et al. Probable chimera M3: M5 in an acute promyelocytic leukemia patient; different clonal response to treatment with transretinoic acid and chemotherapy. Rev Cubana Hematol Inmunol Hemoter [online]. 2004, vol.20, n.2, pp. 0-0. ISSN 1561-2996.

A case of acute promyelocytic leukemia in which the presence of hybrid PML/RAR a gene and the internal tandem duplication of FLT3 (DIT/FLT3)were demonstrated at the time of diagnosis was reported in this paper. After the induction treatment with transretinoic acid and chemotherapy, the cytomorphological study of the bone marrow revealed some change into acute monocytic leukemia (AML-M5). The molecular study revealed that PML/RARa had disappeared but ITD/FLT3 remained. These results suggest that two independent leukemia clones co-exist, that is, one promyeolytic (M3) with chimeric gene PML/RARa and the other monocytic (M5) with ITD/FLT3). Although the hematological and molecular evolution supports such a suggestion, the presence of ITD/FLT3 in clone M3 can not be ignored because it is not a specific marker for AML-M5

Palabras clave : promyelocytic acute leukemia; PML/RARa; ITD/FLT; ATRA.

        · resumen en Español     · texto en Español

 

Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License